Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis of malaria in patients aged 18 years and older. It is active against all stages of Plasmodium species.

For more information regarding the malaria surveillance system, or assistance in completing the form, please call the Malaria Branch at 770-488-7788 or toll-free at 855-856-4713.

Travellers can reduce their risk of malaria illness by taking antimalarial drugs throughout their time abroad as prophylaxis, and by various non-drug interventions which reduce mosquito bites.

60 Degrees Pharmaceuticals, Inc. has launched a new 8-count bottle format for its malaria prophylactic medication, ARAKODA® (tafenoquine), making it more convenient for travelers heading to ...

Tafenoquine was discovered by Walter Reed Army Institute of Research. Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA ® and in Australia as KODATEF ®.

ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older in the United States (U.S.) It is sold under the brand name KODATEF in Australia, where it ...

Continued co-trimoxazole prophylaxis after 96 weeks of ART in HIV-infected children was associated with fewer hospitalizations for both malaria and infection not related to malaria.

Malaria prophylaxis-treatment for children both saves lives and reduces cost , shows a new study from the University of Bergen (UiB).

Travelers can receive prophylaxis medicine at the AHN International Travel Clinic, which is part of Infectious Diseases of Northwestern Pennsylvania, 2314 Sassafras St. Call 814-456-6194 to ...